apremilast (Otezla)
Jump to navigation
Jump to search
Indications
- psoriasis[2]
- active psoriatic arthritis (adults)[1][2]
Contraindications
- NOT recommended for plaque psoriasis (NICE)
Monitor
- body weight (BMI)
- neuropsychiatric effects[2]
Adverse effects
Mechanism of action
More general terms
References
- ↑ Jump up to: 1.0 1.1 FDA News Release: March 21, 2014 FDA approves Otezla to treat psoriatic arthritis http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm390091.htm
- ↑ Jump up to: 2.0 2.1 2.2 2.3 Medical Knowledge Self Assessment Program (MKSAP) 17, 18, American College of Physicians, Philadelphia 2015, 2018.
- ↑ Medscape: apremilast (Rx) https://reference.medscape.com/drug/otezla-apremilast-999915